LncRNA TYMSOS is a novel prognostic biomarker associated with immune infiltration in prostate cancer.
Article in American Journal of Cancer Research (October 2023)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
LncRNA TYMSOS is a novel prognostic biomarker and associated with immune infiltration in prostate cancer
Preprint in Research Square (May 2023)
Importance of long non-coding RNAs in the pathogenesis, diagnosis, and treatment of prostate cancer
Article in Frontiers in Oncology (March 2023)